← Back to Screener
Medicus Pharma Ltd. Common Stock (MDCX)
Price$0.35
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-97.35%
Price vs S&P 500 (4W)27.87%
VGM Score19.40
Market Capitalization$21.47M
All Metrics
Book Value / Share (Quarterly)$0.03
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.56
Price vs S&P 500 (YTD)-86.16%
EPS (TTM)$-2.04
10-Day Avg Trading Volume2.77M
EPS Excl Extra (TTM)$-2.04
EPS (Annual)$-2.05
ROI (Annual)-355.87%
Cash / Share (Quarterly)$0.16
ROA (Last FY)-197.55%
EBITD / Share (TTM)$-1.89
ROE (5Y Avg)-242.43%
Cash Flow / Share (Annual)$-0.87
P/B Ratio16.19x
P/B Ratio (Quarterly)13.62x
Net Income / Employee (Annual)$-2,215,300
Net Interest Coverage (TTM)-178.57x
ROA (TTM)-362.72%
EPS Incl Extra (Annual)$-2.05
Current Ratio (Annual)2.33x
Quick Ratio (Quarterly)1.07x
3-Month Avg Trading Volume4.87M
52-Week Price Return-89.57%
Revenue / Employee (TTM)$0
52-Week High$5.10
EPS Excl Extra (Annual)$-2.05
26-Week Price Return-81.42%
Quick Ratio (Annual)1.81x
13-Week Price Return-72.13%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.22x
Enterprise Value$17.47M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.35
3-Month Return Std Dev186.60%
Net Income / Employee (TTM)$-2,461,500
ROE (Last FY)-355.87%
Net Interest Coverage (Annual)-28.15x
EPS Basic Excl Extra (Annual)$-2.05
P/FCF (TTM)7.07x
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)1.78x
EPS Incl Extra (TTM)$-2.04
Receivables Turnover (Annual)0.00x
ROI (TTM)-244.99%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-117.78%
Year-to-Date Return-75.23%
5-Day Price Return26.33%
EPS Normalized (Annual)$-2.05
ROA (5Y Avg)-4285.53%
Month-to-Date Return34.11%
EBITD / Share (Annual)$-2.01
ROI (5Y Avg)-242.43%
LT Debt / Equity (Quarterly)0.02x
EPS Basic Excl Extra (TTM)$-2.04
P/B Ratio (Annual)9.51x
Book Value / Share (Annual)$0.27
Price vs S&P 500 (13W)-81.88%
Beta1.50x
Revenue / Share (TTM)$0.00
ROE (TTM)-681.88%
52-Week Low$0.25
mGradeF
vgmGradeF
Show chart for
Earnings Surprise History
Q1 26-0.31est. -0.20
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.11
4.11
4.11
4.10
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MDCXMedicus Pharma Ltd. Common Stock | — | — | F | $0.35 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Medicus Pharma Ltd is a clinical-stage holding company that invests in and supports life sciences and biotechnology companies developing novel treatments. The company focuses on advancing therapies through FDA-regulated clinical development to address unmet patient needs and improve therapeutic outcomes.